SAMDI Tech, Inc and Exquiron Announce Partnership Agreement
News Feb 27, 2015
SAMDI Tech and Exquiron are expanding their service offering by entering into a partnership agreement, allowing SAMDI Tech and Exquiron to mutually promote their respective services in Europe and North America. The two companies aim to offer hit discovery, hit profiling, and assay development services, combining their expertise to the benefit of their clients. The partnership provides SAMDI Tech’s clients the added benefit of Exquiron’s broad assay capabilities and lead-like, 250,000 compound collection as well as access of SAMDI Tech’s exclusive label-free, MALDI-TOF capabilities to Exquiron and its clients.
“I am excited to partner with Exquiron as our technology is innovative to the discovery field and coupled with Exquiron’s additional assay capabilities and compound collection we can offer a comprehensive solution to our clients.” said Emilio Córdova Ph.D., MBA, CEO at SAMDI Tech.
SAMDI is a unique label-free assay platform for measurement of complex biochemical activity.
Stephan Fasler Ph.D., CEO of Exquiron commented “We have previously collaborated with SAMDI Tech; the company has been our first choice for entering into this partnership. We are impressed by the novelty and quality of SAMDI Tech’s label-free assay technology, which, coupled with their excellent assay development services, renders SAMDI Tech a company to absolutely work with.”
Faster Test for Cannabis Quality, Potency DevelopedNews
Traditional tests can take upwards of 20 minutes to perform, this new one can be done in under seven.READ MORE
Emissions of an Ozone-Destroying Chemical are Rising AgainNews
A new analysis of long-term atmospheric measurements shows emissions of the ozone-destroying chemical CFC-11 are rising again, most likely from new, unreported production from an unidentified source in East Asia.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018